• MANDEEP KUMAR GUPTA Moradabad Educational Trust Group of Institutions, Faculty of Pharmacy, Moradabad, Uttar Pradesh, India.
  • SUSHIL KUMAR Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, IFTM University, Moradabad, Uttar Pradesh, India.
  • SACHIN CHAUDHARY Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.


Benzopyrones are the club of compounds that can be coumarins or flavonoids. The hydroxyl derivatives of coumarins such as 4-hydroxycoumarins and 7-hydroxycoumarins have extensive biological activities which have employed for the synthesis of miscellaneous coumarin derivatives. These derivatives have exhibited impressive pharmacological and physiological activities such as anticoagulant, antibacterial, antiviral, antitumor, bactericidal, fungicidal, anti-inflammatory agents, and anti-HIV activity. This review comprised pharmacokinetic studies, including absorption, distribution, and metabolism of coumarin analogs along with toxicological studies. The studies of coumarins and their derivatives exhibiting immense pharmacological activity are also summarized in the current study.

Keywords: Benzopyrones, Coumarins, Anticoagulant, Antibacterial, Antiviral, Antitumor.

Author Biographies

MANDEEP KUMAR GUPTA, Moradabad Educational Trust Group of Institutions, Faculty of Pharmacy, Moradabad, Uttar Pradesh, India.

Assistant Professor

SACHIN CHAUDHARY, Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.

Director, School of Pharmaceutical Sciences, IFTM University, Moradabad-244001, Uttar Pradesh, India.


1. Sarker SD, Nahar L. Progress in the chemistry of naturally occurring coumarins. Prog Chem Org Nat Prod 2017;106:241-304.
2. Pangal A, Gazge M, Mane V, Shaikh JA. Various pharmacological aspects of couamrin derivatives: A review. Int J Pharm Res Biosci 2013;2:168-94.
3. Rohini K, Srikumar PS. Therapeutic role of coumarins and coumarin-related compounds. J Thermodyn Catal 2014;5:1-3.
4. Klenkar J, Molnar M. Natural and synthetic coumarins as potential anticancer agents. J Chem Pharm Res 2015;7:1223-38.
5. Constantinou AI, Kamath N, Murley JS. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer 1998;34:1927-34.
6. Egan D, O’Kennedy R, Moran E, Cox D, Prosser E, Thornes RD, et al. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev 1990;22:503-29.
7. Egan DA, O’Kennedy R. Rapid and sensitive determination of coumarin and 7-hydroxycoumarin and its glucuronide conjugate in urine and plasma by high-performance liquid chromatography. J Chromatogr 1992;582:137-43.
8. Finn GJ, Kenealy E, Creaven BS, Egan DA. In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines. Cancer Lett 2002;183:61-8.
9. Lake BG. Coumarin metabolism, toxicity and carcinogenicity: Relevance for human risk assessment. Food Chem Toxicol 1999;37:423-53.
10. Guilet D, Séraphin D, Rondeau D, Richomme P, Bruneton J. Cytotoxic coumarins from calophyllum dispar. Phytochemistry 2001;58:571-5.
11. Murray RDH, Mendez J, Brown SA. Coumarin activity in plants and bio-organism aspects. 2nd ed. John Wiley 1982;45–55.
12. Jamier V, Marut W, Valente S, Chereau C, Chouzenoux S, Nicco C, et al. Chalcone-coumarin derivatives as potential anti-cancer drugs: An in vitro and in vivo investigation. Anticancer Agents Med Chem 2014;14:963-74.
13. Chen H, Walsh CT. Coumarin formation in novobiocin biosynthesis: Beta-hydroxylation of the aminoacyl enzyme tyrosyl-S-novH by a cytochrome P450 novI. Chem Biol 2001;8:301-12.
14. von Weymarn LB, Murphy SE. CYP2A13-catalysed coumarin metabolism: Comparison with CYP2A5 and CYP2A6. Xenobiotica 2003;33:73-81.
15. Ritschel WA, Grummich KW, Kaul S, Hardt TJ. Biopharmaceutical parameters of coumarin and 7-hydroxycoumarin. Die Pharma Ind 1981;43:271-6.
16. Stiefel C, Schubert T, Morlock GE. Bioprofiling of cosmetics with focus and streamlined coumarin analysis. ACS Omega 2017;2:5242-50.
17. Dempsey E, O’Sullivan C, Smyth MR, Egan D, O’Kennedy R, Wang J, et al. Development of an antibody-based amperometric biosensor to study the reaction of 7-hydroxycoumarin with its specific antibody. Analyst 1993;118:411-3.
18. Sharma S, Byrne H, O’Kennedy RJ. Antibodies and antibody-derived analytical biosensors. Essays Biochem 2016;60:9-18.
19. Shilling WH, Crampton RF, Longland RC. Metabolism of coumarin in man. Nature 1969;221:664-5.
20. Moran E, O’Kennedy R, Thornes RD. Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography. J Chromatogr 1987;416:165-9.
21. Pelkonen O, Turpeinen M, Uusitalo J, Rautio A, Raunio H. Prediction of drug metabolism and interactions on the basis of in vitro investigations. Basic Clin Pharmacol Toxicol 2005;96:167-75.
22. Bogan DP, Deasy B, O’Kennedy R, Smyth MR, Fuhr U. Determination of free and total 7-hydroxycoumarin in urine and serum by capillary electrophoresis. J Chromatogr B Biomed Appl 1995;663:371-8.
23. Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 1992;2:227-33.
24. Egan DA, O’Kennedy R. Spectrofluorimetric method for the quantification of 7-hydroxycoumarin in urine and plasma using both extracted and unextracted samples. Analyst 1993;118:201-3.
25. Bogan D, Deasy B, O’Kennedy R, Smyth M. The use of capillary electrophoresis for studying interspecies differences in coumarin metabolism in liver microsomes. Xenobiotica 1996;26:437-48.
26. Pelkonen O, Rautio A, Raunio H, Pasanen M. CYP2A6: A human coumarin 7-hydroxylase. Toxicology 2000;144:139-47.
27. Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, Raunio H. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 1998;28:1203-53.
28. Lacy A, O’Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 2004;10:3797-811.
29. Fentem JH, Fry JR. Metabolism of coumarin by rat, gerbil and human liver microsomes. Xenobiotica 1992;22:357-67.
30. Lin PY, Yeh KS, Su CL, Sheu SY, Chen T, Ou KL, et al. Synthesis and antibacterial activities of novel 4-hydroxy-7-hydroxy- and 3-carboxycoumarin derivatives. Molecules 2012;17:10846-63.
31. Hu Y, Shen Y, Wu X, Tu X, Wang GX. Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents. Eur J Med Chem 2018;143:958-69.
32. Amin KM, Abou-Seri SM, Abdelnaby RM, Rateb HS, Khalil MA, Hussein MM. Synthesis and biological evaluation of novel coumarin derivatives as potential antimicrobial agents. Int J Pharm Pharm Sci 2016;8:109-19.
33. Aziem AA. An efficient and simple synthesis of 2, 3-dihydro-1,3,4- thiazoles, pyrazoles and coumarin containing benzofuran moiety using both conventional and grinding methods. Int J Pharm Pharm Sci 2015;7:61-8.
34. Hamid SJ, Kubba AA. Synthesis and characterization of new coumarin derivatives containing various moieties with antibacterial activities. Int J Pharm Pharm Sci 2015;7:70-4.
35. Tandon R, Ponnan P, Aggarwal N, Pathak R, Baghel AS, Gupta G, et al. Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: Structure-activity relationships. J Antimicrob Chemother 2011;66:2543-55.
36. Reddy DS, Kongot M, Netalkar SP, Kurjogi MM, Kumar R, Avecilla F, et al. Synthesis and evaluation of novel coumarin-oxime ethers as potential anti-tubercular agents: Their DNA cleavage ability and BSA interaction study. Eur J Med Chem 2018;150:864-75.
37. Mangasuli SN, Hosamani KM, Devarajegowda HC, Kurjogi MM, Joshi SD. Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents. Eur J Med Chem 2018;146:747-56.
38. Benci K, Mandi? L, Suhina T, Sedi? M, Klobu?ar M, Kraljevi? Paveli? S, et al. Novel coumarin derivatives containing 1,2,4-triazole, 4,5-dicyanoimidazole and purine moieties: Synthesis and evaluation of their cytostatic activity. Molecules 2012;17:11010-25.
39. Cheng JF, Chen M, Wallace D, Tith S, Arrhenius T, Kashiwagi H, et al. Discovery and structure-activity relationship of coumarin derivatives as TNF-alpha inhibitors. Bioorg Med Chem Lett 2004;14:2411-5.
40. Lee S, Sivakumar K, Shin WS, Xie F, Wang Q. Synthesis and anti-angiogenesis activity of coumarin derivatives. Bioorg Med Chem Lett 2006;16:4596-9.
41. Chen W, Tang W, Lou L, Zhao W. Pregnane, coumarin and lupane derivatives and cytotoxic constituents from Helicteres angustifolia. Phytochemistry 2006;67:1041-7.
42. Nofal ZM, El-Zahar MI, El-Karim SS. Novel coumarin derivatives with expected biological activity. Molecules 2000;5:99-113.
43. Lou LL, Zhao P, Cheng ZY, Guo R, Yao GD, Wang XB, et al. A new coumarin from Juglans mandshurica maxim induce apoptosis in hepatocarcinoma cells. Nat Prod Res 2018;1-3. Avaliable from: 10.1080/14786419.2018.1434646 [Last accessed on 2018 Feb 04].
44. Tan S, He F, Kong T, Wu J, Liu Z. Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors. Bioorg Med Chem 2017;25:4123-32.
45. Lv N, Sun M, Liu C, Li J. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents. Bioorg Med Chem Lett 2017;27:4578-81.
46. Yu H, Hou Z, Tian Y, Mou Y, Guo C. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents. Eur J Med Chem 2018;151:434-49.
47. Batran RZ, Kassem AF, Abbas EMH, Elseginy SA, Mounier MM. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells. Bioorg Med Chem 2018;26:3474-90.
48. Ayati A, Bakhshaiesh TO, Moghimi S, Esmaeili R, Majidzadeh-A K, Safavi M, et al. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. Eur J Med Chem 2018;155:483-91.
49. Singh H, Singh JV, Gupta MK, Saxena AK, Sharma S, Nepali K, et al. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Bioorg Med Chem Lett 2017;27:3974-9.
50. Guo Y, Wang Y, Li H, Wang K, Wan Q, Li J, et al. Novel nitric oxide donors of phenylsulfonylfuroxan and 3-benzyl coumarin derivatives as potent antitumor agents. ACS Med Chem Lett 2018;9:502-6.
51. Luo G, Li X, Zhang G, Wu C, Tang Z, Liu L, et al. Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ER?/VEGFR-2 ligands for treatment of breast cancer. Eur J Med Chem 2017;140:252-73.
52. Bu M, Cao T, Li H, Guo M, Yang BB, Zeng C, et al. Synthesis and biological evaluation of novel steroidal 5?,8?-epidioxyandrost-6-ene- 3?-ol-17-(O-phenylacetamide)oxime derivatives as potential anticancer agents. Bioorg Med Chem Lett 2017;27:3856-61.
53. Al-Haiza MA, Mostafa MS, El-Kady MY. Synthesis and biological evaluation of some new coumarin derivatives. Molecules 2003;8:275-86.
54. López-Rojas P, Janeczko M, Kubi?ski K, Amesty Á, Mas?yk M, Estévez- Braun A, et al. Synthesis and antimicrobial activity of 4-substituted 1,2,3-triazole-coumarin derivatives. Molecules 2018;23:E199.
55. Tiwari SV, Seijas JA, Vazquez-Tato MP, Sarkate AP, Karnik KS, Nikalje APG, et al. Facile synthesis of novel coumarin derivatives, antimicrobial analysis, enzyme assay, docking study, ADMET prediction and toxicity study. Molecules 2017;22:E1172.
56. Kostova I, Raleva S, Genova P, Argirova R. Structure-activity relationships of synthetic coumarins as HIV-1 inhibitors. Bioinorg Chem Appl 2006;2006:68274.
57. Jashari A, Hey-Hawkins E, Mikhova B, Draeger G, Popovski E. An improved synthesis of 4-chlorocoumarin-3-sulfonyl chloride and its reactions with different bidentate nucleophiles to give pyrido[1’,2’:2,3]- and thiazino[3’,2’:2,3]-1,2,4-thiadiazino[6,5-c] benzopyran-6-one 7,7-dioxides. Molecules 2007;12:2017-28.
58. Majumdar M. Antioxidant activity and inhibitory potential of few Indian medicinal plants against key hyperglycemic enzymes. Res J Biotechnol 2012;7:186-91.
59. Goudgaon NM, Sheshikant BU, Dhage D. Synthesis and biological activities of 3-{6-[3-(substitutedphenyl)-1-phenyl-1h-pyrazol-4-yl]- 2-thioxo-1, 2, 5, 6-tetrahydropyrimidin-4-yl}-2h-chromen-2-ones. Heterolett 2012;2:154-61.
60. Melagraki G, Afantitis A, Igglessi-Markopoulou O, Detsi A, Koufaki M, Kontogiorgis C, et al. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur J Med Chem 2009;44:3020-6.
61. Singh TS, Rao BS, Mohan H, Mittal JP. A pulse radiolysis study of coumarin and its derivatives. J Photochem Photobiol Chem 2002;153:163-71.
62. Beillerot A, Domínguez JC, Kirsch G, Bagrel D. Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin. Bioorg Med Chem Lett 2008;18:1102-5.
63. Nicolaides DN, Gautam DR, Litinas KE, Hadjipavlou-Litina DJ, Fylaktakidou KC. Synthesis and evaluation of the antioxidant and antiinflammatory activities of some benzo[l]khellactone derivatives and analogues. Eur J Med Chem 2004;39:323-32.
64. Sreeja S, Mathan S, Kumaran J. Design, Synthesis and pharmacological evaluation of new coumarin derivatives. Int J Adv PharmBiol Sci 2012;2:80-91.
65. Gummudavelly S, Ranganath YS, Bhasker S, Rajkumar N. Synthesis and biological screening of some novel coumarin derivatives. Asian J Res Chem 2009;2:46-8.
66. Kontogiorgis CA, Hadjipavlou-Litina DJ. Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett 2004;14:611-4.
67. Chen LZ, Sun WW, Bo L, Wang JQ, Xiu C, Tang WJ, et al. New arylpyrazoline-coumarins: Synthesis and anti-inflammatory activity. Eur J Med Chem 2017;138:170-81.
68. Liu BY, Zhang C, Zeng KW, Li J, Guo XY, Zhao MB, et al. Anti-inflammatory prenylated phenylpropenols and coumarin derivatives from Murraya exotica. J Nat Prod 2018;81:22-33.
69. Keri RS, Hosamani KM, Shingalapur RV, Hugar MH. Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety. Eur J Med Chem 2010;45:2597-605.
70. Zhou X, Wang XB, Wang T, Kong LY. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues. Bioorg Med Chem 2008;16:8011-21.
71. Costas-Lago MC, Besada P, Rodríguez-Enríquez F, Viña D, Vilar S, Uriarte E, et al. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors. Eur J Med Chem 2017;139:1-1.
72. Jiang N, Huang Q, Liu J, Liang N, Li Q, Li Q, et al. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer’s disease. Eur J Med Chem 2018;146:287-98.
73. Lan JS, Ding Y, Liu Y, Kang P, Hou JW, Zhang XY, et al. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer’s disease. Eur J Med Chem 2017;139:48-59.
74. Yang HL, Cai P, Liu QH, Yang XL, Li F, Wang J, et al. Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-? aggregation for the treatment of Alzheimer’s disease. Eur J Med Chem 2017;138:715-28.
75. Jalili-Baleh L, Forootanfar H, Küçükk?l?nç TT, Nadri H, Abdolahi Z, Ameri A, et al. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of alzheimer’s disease based on coumarin and lipoic acid scaffolds. Eur J Med Chem 2018;152:600-14.
76. Baruah P, Basumatary G, Yesylevskyy SO, Aguan K, Bez G, Mitra S, et al. Novel coumarin derivatives as potent acetylcholinesterase inhibitors: Insight into efficacy, mode and site of inhibition. J Biomol Struct Dyn 2018;1-6. Avaliable from: 10.1080/07391102.2018.1465853. [Last accessed on 2018 May 04].
77. Vafadarnejad F, Mahdavi M, Karimpour-Razkenari E, Edraki N, Sameem B, Khanavi M, et al. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity. Bioorg Chem 2018;77:311-9.
78. Manolov I, Maichle-Moessmer C, Danchev N. Synthesis, structure, toxicological and pharmacological investigations of 4-hydroxycoumarin derivatives. Eur J Med Chem 2006;41:882-90.
79. Chimenti F, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, et al. Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: Biological activity and computational study. Bioorg Med Chem Lett 2004;14:3697-703.
80. Oketch-Rabah HA, Mwangi JW, Lisgarten J, Mberu EK. A new antiplasmodial coumarin from Toddalia asiatica roots. Fitoterapia 2000;71:636-40.
81. Himangini, Pathak DP, Sharma V, Kumar S. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum. Bioorg Med Chem Lett 2018;28:1566-9.
82. Yadav N, Agarwal D, Kumar S, Dixit AK, Gupta RD, Awasthi SK, et al. In vitro antiplasmodial efficacy of synthetic coumarin-triazole analogs. Eur J Med Chem 2018;145:735-45.
83. Siddiqui N, Arshad MF, Khan SA. Synthesis of some new coumarin incorporated thiazolyl semicarbazones as anticonvulsants. Acta Pol Pharm 2009;66:161-7.
84. Sashidhara KV, Kumar A, Kumar M, Srivastava A, Puri A. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives. Bioorg Med Chem Lett 2010;20:6504-7.
85. Fais A, Corda M, Era B, Fadda MB, Matos MJ, Quezada E, et al. Tyrosinase inhibitor activity of coumarin-resveratrol hybrids. Molecules 2009;14:2514-20.
86. Singh LR, Kumar A, Upadhyay A, Gupta S, Palanati GR, Sikka K, et al. Discovery of coumarin-dihydroquinazolinone analogs as niacin receptor 1 agonist with in vivo anti-obesity efficacy. Eur J Med Chem 2018;152:208-22.
87. Sun H, Song X, Tao Y, Li M, Yang K, Zheng H, et al. Synthesis & ?-glucosidase inhibitory and glucose consumption-promoting activities of flavonoid-coumarin hybrids. Future Med Chem 2018;10:1055-66.
88. Kazmi M, Zaib S, Ibrar A, Amjad ST, Shafique Z, Mehsud S, et al. A new entry into the portfolio of ?-glucosidase inhibitors as potent therapeutics for Type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Bioorg Chem 2018;77:190-202.
14 Views | 27 Downloads
How to Cite
GUPTA, M. K., S. KUMAR, and S. CHAUDHARY. “COUMARINS: A UNIQUE SCAFFOLD WITH VERSATILE BIOLOGICAL BEHAVIOR”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 3, Feb. 2019, pp. 27-38,
Review Article(s)

Most read articles by the same author(s)